The stock of Cingulate Inc (CING) has seen a -21.13% decrease in the past week, with a -25.33% drop in the past month, and a 18.64% flourish in the past quarter. The volatility ratio for the week is 7.55%, and the volatility levels for the past 30 days are at 7.70% for CING. The simple moving average for the past 20 days is -22.96% for CING’s stock, with a -65.30% simple moving average for the past 200 days.
Is It Worth Investing in Cingulate Inc (NASDAQ: CING) Right Now?
CING has 36-month beta value of -0.91. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CING is 2.05M, and currently, short sellers hold a 1.87% ratio of that float. The average trading volume of CING on November 07, 2024 was 3.84M shares.
CING) stock’s latest price update
The stock price of Cingulate Inc (NASDAQ: CING) has dropped by -7.95 compared to previous close of 3.65. Despite this, the company has seen a fall of -21.13% in its stock price over the last five trading days. globenewswire.com reported 2024-10-08 that KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) — Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, recently joined the cast of the Big Biz Show, a business and finance broadcast, to discuss Cingulate’s lead Phase 3 asset CTx-1301 for the treatment of ADHD, its plans for commercialization, and other therapeutic areas where the company’s PTR™ technology may be applied.
CING Trading at -33.58% from the 50-Day Moving Average
After a stumble in the market that brought CING to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.80% of loss for the given period.
Volatility was left at 7.70%, however, over the last 30 days, the volatility rate increased by 7.55%, as shares sank -22.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -65.99% lower at present.
During the last 5 trading sessions, CING fell by -21.13%, which changed the moving average for the period of 200-days by -92.13% in comparison to the 20-day moving average, which settled at $4.36. In addition, Cingulate Inc saw -96.34% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CING starting from Myers Laurie, who sale 202 shares at the price of $4.17 back on Aug 15 ’24. After this action, Myers Laurie now owns 0 shares of Cingulate Inc, valued at $841 using the latest closing price.
Stock Fundamentals for CING
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 1.84 for the gross margin
The net margin for Cingulate Inc stands at 0.0. The total capital return value is set at -8.88. Equity return is now at value -1364.73, with -368.85 for asset returns.
Based on Cingulate Inc (CING), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -52.48. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is -0.07.
Currently, EBITDA for the company is -22.18 million with net debt to EBITDA at 0.0. When we switch over and look at the enterprise to sales, we see a ratio of -0.0. The receivables turnover for the company is -2381.23for trailing twelve months and the total asset turnover is -750.94. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
To put it simply, Cingulate Inc (CING) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
